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distribution is that normal diiferentiation is aifected in non-balding 
region follicles because these quantities of glycogen are seen much 
higher up in the normal follicle. 
At the clinical level, hair in non-balding regions displays the 
properties of normal hair, but at the ultrastructural level follicles 
clearly showed properties of active area alopecia follicles. These 
early changes in the melanocytes and outer root sheath cells could 
be primary changes in the pathology consistent with the apparent 
importance of melanocytes in the disease or could be secondary 
changes due to disturbance or abnormalities of the dermal papilla, 
which also showed multiple changes. The large cell-surface to 
volume ratio of melanocytes may well make them exhibit early 
signs of general distress in the follicle , perhaps due to perturbance 
of the normal regnlatory factors produced by the dermal papilla. 
Further studies of the sub-clinical condition of alopecia areata may 
reveal important information about the etiology of the disease. 
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T he cause of alopecia areata (AA) is not known. The favored hypothesis is that it results from an autoim­mune response to hair follicles (HFs), based on indirect observations that have recently been re­viewed [1] . These include the systemic nature of the 
disease, which may involve hair, eyes, and nails ; its association with 
other autoimmune diseases and autoantibodies to other organs; the 
presence of a lymphocytic infiltrate around and in hair bulbs during 
active disease; non-specific alterations in the number and/or func­
tion of circulating T cells; deposits of irrununoglobulin and com­
plement around HFs particularly at the edge of active lesions; 
increased expression of class I and II major histocompatibility 
complex antigens and of Langerhans cells in hair bulbs in active 
disease; and the fact that effective therapies for AA all have as a 
common denominator a suppression in dle number or function of 
irrunune cells in skin. The major problem with this hypothesis is 
that, until recently, there was no evidence of an abnormal immune 
response directed specifically to HFs in AA. 
We recently have made tllree significant observations that 
strongly support the hypothesis that AA is an autoirrunune disease. 
The first is that HFs express unique antigens, and tllat some of these 
are the target of autoimmune responses [2]. The presence of unique 
antigens in HFs was demonstrated by probing Western blots of 
extracts of isolated human HFs with sera of normal persons. Most 
individuals had low levels (titer of20) of antibodies that reacted to 
multiple antigens in HFs. Many of these antigens were specific for 
HF and were not expressed in adjacent epidermis or dermis. 
Unique HF-antigens extractable with NP-40 and 6 M urea had 
approxiInate Mw of84, 105, 115, and 125 kD and 115,145,200, 
and 220 kD, respectively. Most of these antigens were autoanti­
gens, as they reacted with antibodies present in the donor's own 
serum . The presence of unique antigens in HF that can trigger 
autoimmune responses provide the framework necessary to explain 
the selective damage to HF that occurs in AA. 
Reprint requests to: Dr. Jean-Claude Bystryn, Department of Derma to 1-
ogy, NYU Medical Center, 560 First Avenue, New York, NY 10016. 
Second, antibodies to some antigens that are selectively ex­
pressed in HFs are present more frequently and in higher levels in 
patients with AA [3]. High-titer antibodies (>1:80) to HF were 
detected in all AA patients (100%) but in less than 44% of controls 
using a Western immunoblot assay [3]. The antibodies were 
predominantly directed to one or more antigens of approximately 
44, 47, 50, 52, and 57 kD. The incidence of antibodies to these 
antigens in AA was up to seven times more frequent than in control 
sera and their level up to 13 times greater. The 44-52-kD antigens 
reacting witll AA antibodies were HF
' 
specific. All were expressed 
in HF extr acts , but could not be detected in similar extracts of 
adjacent scalp epidermis or dermis obtained from the same individ­
ual or other control tissues. By immunofluorescence some AA 
patients react with HF but not with adjacent epidermis or dermis 
confirming the presence of HF-specific antibodies in AA. 
These diiferences were statistically significant for all five antigens . 
The nature of the HF antibody response in AA was further examined 
by analyzing the immunoglobulin isotype usage in AA and control 
persons. The anti-HF antibodies in control persons were present in 
low titer and were both IgM and IgG antibodies, whereas in AA the 
HF antibodies were high titer and predominantly IgG. 
More recently , we have conducted studies to identify the sub­
set(s) of cells in HF that are the target(s) of immune responses in 
AA. We have developed methods to culture individually the maj or 
HF cell subpopulations including, for the first time, HF melano­
cytes [4]. We believe it is critical to use cells derived from HFs 
rather than cells of similar histologic type derived from epidermis to 
study immune abnormalities associated with AA, based on evidence 
that similar cells derived from these two sites are immunologically 
different. As a result, the use of cells derived from epidermis as 
targets in immune assays may fail to reveal immune responses 
directed specifically to cells of HF. 
TIrird, using isolated subsets ofHF cells as targets, we found that AA 
antibodies appear to be directed to both keratinocytes and melanocytes 
in HF. In these studies we studied the ability of antibodies in AA and 
control individuals to react to pure populations of keratinocytes and 
melanocytes derived from HF. Antibodies to HF keratinocytes, as-
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sayed by immunoblotting, were present in all patients with AA. The 
antibodies were predominantly directed to one or more antigens of 
approximately 48-50, 52-54, 58-60, and 62-64 kD. Antibodies to 
the 58-60-kD and the 52-54-kD antigens were present in 80% and 
86%, respectively of 49 patients with AA but in only 14% and 27% of 
22 control individuals. These diJferences were statistically significant. 
These antigens were expressed by keratinocytes derived from HF but 
could not be detected on keratinocytes derived from epidennis, 
indicating that keratinocytes in these two diJferent locations are 
antigenically diJferent. The incidence and level of HF keratinocyte 
antibodies correlated with disease severity. Patients with more severe 
disease (i.e., A. tota/is and A. universa/is) had a significantly higher 
incidence of antibodies to the 62-64-, 58-60-, and 48-50-kD HF 
keratinocyte antigens than patients with less severe patchy AA. 
Preliminary results also suggest AA antibodies react to HF 
melanocytes. By indirect immunofluorescence, IgG antibodies to 
cytoplasmic antigens in fixed HF melanocytes were present in most 
AA patients (82%) but in only 10% of controls. The identity and 
specificity of the HF melanocytes antigens defined by AA antibod­
ies is currently under investigation. 
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These results indicate that HF express unique antigens not 
found in adjacent scalp tissue, and that abnormal circulating 
antibodies to some HF-specific antigens are present in individ­
uals with AA. This provides the first direct evidence that 
abnormal immune responses specifically directed to antigens 
expressed only in HF are associated with AA. These findings 
strongly support the hypothesis that AA results from abnormal 
autoimmune responses to HF and can provide an explanation for 
the selective damage to HF that occurs in this disease. 
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Cytokine Patterns in Alopecia Areata Before and 
After Topical Immunotherapy 
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T he events that induce premature telogen or dystro­phic anagen growth patterns in alopecia areata (AA) are so far not understood. Although the nature of the noxious signal is still unknown, it has been assumed that CD4 +T lymphocytes might trigger the hair loss 
[1]. These T lymphocytes invade the hair follicles and apparently 
interact with the hair-follicle cells. Such interaction may occur 
either by direct cell-to-cell contact and cytotoxicity, or indirectly 
by lymphokines that might affect the differentiation and growth of 
follicular epithelial cells. Because the T lymphocytes obviously do 
not promote cytotoxic activity we hypothesize that AA is triggered 
by soluble mediators that "switch off" the hair cycle, resulting in 
hair loss. The presence of such mediators (e.g., interferon [IFN]-,)" 
tumor necrosis factor [TNF]-O') would explain the increased adhe­
sion molecule expression on affected hair follicles and the non­
destructive nature of the disease. 
At present, topical immunotherapy with a potent contact allergen 
such as diphenylcyclopropenone (DCP) appears to be superior to 
other modes of treatment [2]. Why an allergic contact dermatitis is 
able to reverse the pathogenic process and induce hair regrowth is 
still unknown. If it is true that AA results from a distinct cytokine 
pattern, we can infer that the beneficial effect of DCP should be 
mediated by cytokines locally released during the contact allergy. 
To address this question we performed a semiquantitative reverse­
transcriptase polymerase chain reaction [3] with RNA extracted 
from scalp biopsies that were obtained from patients with AA 
Reprint requests to: Dr. Rolf Hoffinann, Department of Dermatology, 
Philipp University, Deutschhausstra/3e 9, 35033 Marburg, Germany. 
Abbreviations: DCP, diphenylcyclopropenone. 
before and after successful treatment with DCP, and from healthy 
controls. We detected a T-cell response with increased steady-state 
mRNA levels for IFN-,)" interleukin (IL)-l{3 and IL-2 in untreated 
AA of the totalis type. Mter DCP treatment we found increased 
mRNA steady-state levels for IL-2, IL-8, IL-l0, and TNF-O'. No 
transcripts for IL-4 were found, whereas IL- 6 mRNA expression 
was low. IFN-')' and IL-l{3 transcripts were increased as compared 
to controls but, when compared to untreated AA, the overall 
expression level was reduced by 60% and 15% for IFN-')' and IL-l{3, 
respectively. 
With our results we provide experimental evidence that cyto­
kines participate in the pathogenesis of AA. We detected increased 
lesional levels ofIFN-,)" IL-2, and IL-l{3 transcripts in scalp biopsies 
from patients with untreated AA, corresponding to a cytokine 
pattern of the Thl T -helper type. As IFN-')' is known to be crucially 
involved in adhesion molecule expression on hair follicles, our 
fmdings offer an explanation for the aberrant expression of mole­
cules such as ICAM-l and HLA-DR on affected hair follicles. 
Furthermore, IL-l{3 has been shown to inhibit hair growth ill vitro 
[4] , and our results suggest that IL-l {3 may trigger the harr growth 
arrest even ill vivo. 
The pathways by which DCP therapy induces hair regrowth are 
unknown. However, we assume a substantial action of IL-l0. IL-10 
has been characterized by its ability to inhibit Thl cytokine 
production. Several lines of evidence, however, indicate a more 
pleiotropic function of IL-l 0 as a modulator of immune responses 
[ 5]. If we assume that IL-l0 is involved in the induction of hair 
regrowth by DCP therapy, this hypothesis would explain the 
decreased expression of ICAM-l and HLA-DR molecules on 
hair-follicle keratinocytes. This hypothesis is supported by the 
0022-202X/95/$09.50 • SSDI0022-202X(95)OOI10-7 • Copyright © 1995 by The Society for Investigative Dermatology, Inc. 
